日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A novel missense variant in TNFAIP3 associated with autoimmunity reveals the contribution of STAT1/mTOR pathways

TNFAIP3 中一种与自身免疫相关的新型错义变异揭示了 STAT1/mTOR 通路的作用

期刊:Clinical and Experimental Immunology
影响因子:
doi:10.1093/cei/uxaf048
Potjewijd, Judith; Koenen, Hans J P M; van der Made, Caspar I; van Rijssen, Esther; He, Xuehui; Ysermans, Renee; Ungethum, Liset; Theunissen, Ruud; Schurgers, Leon J; Damoiseaux, Jan; van Paassen, Pieter; Smeets, Ruben L
STAT1
mTOR
AIP
JAK/STAT
信号转导
免疫/内分泌
发表日期：2025
文献求助 收藏

Thrombin formation via the intrinsic coagulation pathway and von Willebrand factor reflect disease severity in COVID-19

通过内源性凝血途径形成的凝血酶和血管性血友病因子反映了新冠肺炎的疾病严重程度。

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2022.281693
Busch, Matthias H; Timmermans, Sjoerd A M E G; Van Kuijk, Sander M J; Aendekerk, Joop P; Ysermans, Renée; Van Doorn, Daan P C; Potjewijd, Judith; Van de Poll, Marcel C G; Van der Horst, Iwan C C; Damoiseaux, Jan G M C; Spronk, Henri M H; Cate, Hugo Ten; Reutelingsperger, Chris P; Nagy, Magdolna; Van Paassen, Pieter
肺炎
新冠
微生物学
发表日期：2023
文献求助 收藏

Adding low dose cyclophosphamide to rituximab for remission-induction may prolong relapse-free survival in patients with ANCA vasculitis: A retrospective study

在利妥昔单抗诱导缓解治疗中加入低剂量环磷酰胺可能延长ANCA血管炎患者的无复发生存期：一项回顾性研究

期刊:Journal of Translational Autoimmunity
影响因子:3.6
doi:10.1016/j.jtauto.2022.100178
Ysermans, Renée; Busch, Matthias H; Aendekerk, Joop P; Damoiseaux, Jan G M C; van Paassen, Pieter
发表日期：2023
文献求助 收藏

Annexin A1 Is Associated with Adverse Clinical Outcomes in Patients with COVID-19

Annexin A1 与 COVID-19 患者的不良临床结局相关

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm11247486
Busch, Matthias H; Timmermans, Sjoerd A M E G; Aendekerk, Joop P; Ysermans, Renée; Amiral, Jean; Damoiseaux, Jan G M C; Reutelingsperger, Chris P; Paassen, Pieter van
Annexin A1
发表日期：2022
文献求助 收藏